Hopewell Therapeutics' new class of mRNA therapies, using organ and cell-specific biodegradable lipid nanoparticles (LNPs) to address unmet medical needs, including immuno-oncology and regenerative medicine.
Location: United States, Massachusetts, Woburn
Employees: 11-50
Total raised: $25M
Founded date: 2006
Investors 1
| Date | Name | Website |
| 13.10.2022 | IMO Ventur... | imo.vc/ |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.06.2023 | Seed | $25M | Massachuse... |
Mentions in press and media 2
| Date | Title | Description | Source |
| 07.06.2023 | Hopewell Therapeutics Raises $25M in Seed Financing | Hopewell Therapeutics, a Woburn, MA-based biotechnology company with a differentiated lipid nanopart... | finsmes.co... |
| - | Hopewell Therapeutics | “Hopewell Therapeutics' new class of mRNA therapies, using organ and cell-specific biodegradable lip... | fastfounde... |